Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.
Hikma Pharmaceuticals PLC HIK shares inched up 0.10% to £19.84 Monday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100 Index UKX falling 0.35% to ...
The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback